Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)

HKG:9989 Statistics

Total Valuation

HKG:9989 has a market cap or net worth of HKD 17.75 billion. The enterprise value is 17.81 billion.

Market Cap	17.75B
Enterprise Value	17.81B

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	May 26, 2025

Share Statistics

Current Share Class	220.09M
Shares Outstanding	n/a
Shares Change (YoY)	-0.56%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	431.45M

Valuation Ratios

The trailing PE ratio is 38.65.

PE Ratio	38.65
Forward PE	n/a
PS Ratio	3.02
PB Ratio	1.31
P/TBV Ratio	1.68
P/FCF Ratio	9.61
P/OCF Ratio	8.81
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.69, with an EV/FCF ratio of 9.65.

EV / Earnings	38.78
EV / Sales	3.03
EV / EBITDA	20.69
EV / EBIT	32.63
EV / FCF	9.65

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.25.

Current Ratio	2.39
Quick Ratio	1.16
Debt / Equity	0.25
Debt / EBITDA	3.32
Debt / FCF	1.83
Interest Coverage	1.83

Financial Efficiency

Return on equity (ROE) is 3.23% and return on invested capital (ROIC) is 2.50%.

Return on Equity (ROE)	3.23%
Return on Assets (ROA)	2.28%
Return on Invested Capital (ROIC)	2.50%
Return on Capital Employed (ROCE)	4.86%
Revenue Per Employee	3.06M
Profits Per Employee	238,445
Employee Count	1,926
Asset Turnover	0.31
Inventory Turnover	0.73

Taxes

In the past 12 months, HKG:9989 has paid 89.78 million in taxes.

Income Tax	89.78M
Effective Tax Rate	17.09%

Stock Price Statistics

The stock price has increased by +22.12% in the last 52 weeks. The beta is 0.35, so HKG:9989's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+22.12%
50-Day Moving Average	5.72
200-Day Moving Average	5.11
Relative Strength Index (RSI)	45.55
Average Volume (20 Days)	766,125

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9989 had revenue of HKD 5.88 billion and earned 459.25 million in profits. Earnings per share was 0.31.

Revenue	5.88B
Gross Profit	1.87B
Operating Income	701.16M
Pretax Income	525.28M
Net Income	459.25M
EBITDA	974.13M
EBIT	701.16M
Earnings Per Share (EPS)	0.31

Balance Sheet

The company has 3.37 billion in cash and 3.37 billion in debt, giving a net cash position of -853,016.

Cash & Cash Equivalents	3.37B
Total Debt	3.37B
Net Cash	-853,016
Net Cash Per Share	n/a
Equity (Book Value)	13.58B
Book Value Per Share	9.22
Working Capital	5.98B

Cash Flow

In the last 12 months, operating cash flow was 2.01 billion and capital expenditures -168.21 million, giving a free cash flow of 1.85 billion.

Operating Cash Flow	2.01B
Capital Expenditures	-168.21M
Free Cash Flow	1.85B
FCF Per Share	n/a

Margins

Gross margin is 31.77%, with operating and profit margins of 11.91% and 7.80%.

Gross Margin	31.77%
Operating Margin	11.91%
Pretax Margin	8.93%
Profit Margin	7.80%
EBITDA Margin	16.55%
EBIT Margin	11.91%
FCF Margin	31.37%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 5.08%.

Dividend Per Share	0.27
Dividend Yield	5.08%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	68.39%
Buyback Yield	0.56%
Shareholder Yield	5.63%
Earnings Yield	2.59%
FCF Yield	10.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	8